Nxera Pharma
25 Nov, 2024
Nxera Pharma President and CEO, Chris Cargill. Courtesy – Nxera Pharma.
The company, which has a European R & D flagship facility at Granta Park, is reaping the rewards of record levels of milestone payments and a substantial uptick in its broad treatments portfolio.
In the nine months to end-September, revenues rocketed to $145.5m – up $105.8m from the prior corresponding period.